Adcock Ingram Holdings Ltd

JSE:AIP (South Africa)  
R 55.17 (+2.45%) Jun 7
10.04
P/B:
1.53
Market Cap:
R 8.33B ($ 440.44M)
Enterprise V:
R 8.71B ($ 460.15M)
Volume:
33.35K
Avg Vol (2M):
120.81K
Also Trade In:
Volume:
33.35K
Avg Vol (2M):
120.81K
PE Ratio PS Ratio PB Ratio Price-to-FCF Market Cap
Current and historical daily PE Ratio for Adcock Ingram Holdings Ltd ( ) from 2008 to Jun 08 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Adcock Ingram stock (JSE:AIP) PE ratio as of Jun 08 2024 is 10.04. More Details

Adcock Ingram Holdings Ltd (JSE:AIP) PE Ratio (TTM) Chart

To

Adcock Ingram Holdings Ltd (JSE:AIP) PE Ratio (TTM) Historical Data

Total 1254
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 14
Adcock Ingram PE Ratio (TTM) Historical Data
Date PE Ratio (TTM) Data Date PE Ratio (TTM) Data
2024-06-08 10.1 2024-04-04 9.9
2024-06-07 10.1 2024-04-03 10.0
2024-06-06 9.8 2024-04-02 10.0
2024-06-05 10.0 2024-03-28 10.0
2024-06-04 10.2 2024-03-27 10.1
2024-06-03 10.3 2024-03-26 10.1
2024-05-31 10.3 2024-03-25 10.2
2024-05-30 9.9 2024-03-22 10.1
2024-05-28 10.0 2024-03-20 9.8
2024-05-27 9.9 2024-03-19 9.8
2024-05-24 9.8 2024-03-18 9.8
2024-05-23 9.9 2024-03-15 9.9
2024-05-22 10.1 2024-03-14 9.8
2024-05-21 10.0 2024-03-13 9.8
2024-05-20 10.1 2024-03-12 10.1
2024-05-17 10.0 2024-03-11 9.9
2024-05-16 9.9 2024-03-08 10.1
2024-05-15 10.1 2024-03-07 10.0
2024-05-14 10.1 2024-03-06 10.1
2024-05-13 10.3 2024-03-05 10.1
2024-05-10 10.3 2024-03-04 10.3
2024-05-09 10.3 2024-03-01 10.1
2024-05-08 10.1 2024-02-29 10.2
2024-05-07 10.0 2024-02-28 9.8
2024-05-06 10.0 2024-02-27 10.0
2024-05-03 9.6 2024-02-26 9.8
2024-05-02 10.0 2024-02-23 9.8
2024-04-30 10.1 2024-02-22 9.7
2024-04-29 10.0 2024-02-21 9.6
2024-04-26 10.1 2024-02-20 9.8
2024-04-25 10.1 2024-02-19 10.0
2024-04-24 10.1 2024-02-16 9.8
2024-04-23 10.0 2024-02-15 9.8
2024-04-22 9.8 2024-02-14 9.9
2024-04-19 10.0 2024-02-13 10.0
2024-04-18 10.0 2024-02-12 10.1
2024-04-17 9.9 2024-02-09 10.1
2024-04-16 9.8 2024-02-08 9.8
2024-04-15 9.8 2024-02-07 10.0
2024-04-12 10.0 2024-02-06 10.0
2024-04-11 10.1 2024-02-05 10.0
2024-04-10 10.1 2024-02-02 10.4
2024-04-09 9.8 2024-02-01 10.0
2024-04-08 9.8 2024-01-31 10.2
2024-04-05 9.6 2024-01-30 10.2

Adcock Ingram Holdings Ltd (JSE:AIP) PE Ratio (TTM) Comparison

Company Market Cap(Mil) PE Ratio (TTM)

Business Description

Business Description

Description
Adcock Ingram Holdings Ltd is a drug manufacturing company. The company manufactures, markets, and distributes a wide range of healthcare products. The company generates roughly two-thirds of its sales from the private sector, with the remaining from the public sector. Adcock operates in four broad areas: renal disease, medicine delivery, transfusion therapies, and blood and specialized pharmaceuticals. The company generates the vast majority of its revenue in southern Africa, followed by the rest of Africa and India.